Collagen Medical is a pre-clinical stage specialty pharmaceutical company. It develops targeted magnetic resonance imaging (MRI) contrast agents to diagnose and stage fibrotic disease as well as to assess response to therapeutic interventions. The company uses technology that enables specific three-dimensional mapping of fibrosis within target organs, providing clinicians with the means to diagnose and manage disease in a minimally invasive manner.